Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01) (asn01)

September 4, 2015 updated by: Doris Meister, Kyberg Vital GmbH

Dietary Intervention of Stress-Induced Neurovegetative Disorders in Men and Women With a Specific Amino Acid Composition With Micronutrients

Psychosocial stress leads to altered neuroendocrine functions, such as serotonergic dysfunction, as well as alterations of the autonomic nervous system and the hypothalamic-pituitary-adrenal (HPA) axis activity resulting in an imbalance between inhibitory and excitatory neurotransmitters. Clinical consequences include, inter alia, neurovegetative disorders, higher resting heart rate, hypertension, depressive symptoms, sleep disturbances, irregular body-weight changes, and insulin resistance. Poor dietary intake of the essential amino acid L-tryptophane as a precursor to 5-hydroxytryptamine (HT, serotonin) increases sensitivity to stress.

It is therefore the investigators hypothesis that daily oral administration of an amino acid mixture (dosage 3.8 g/day) with micronutrients specifically designed to decrease neurovegetative disorders will target these neuroendocrine and metabolic alterations in adults with psychosocial stress. The principal endpoints will be a decrease in points in the psychological-neurological questionnaire (PNF).

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 13053
        • Cardiological Outpatient Practice Elke Parsi, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 18-65 Years
  • Psychological-Neurological Questionnaire (PNF): 30 - 50 Points

Exclusion Criteria:

  • Age: < 18 and > 65 Years
  • Psychological neurological questionnaire (PNF): < 30 and > 50 Points
  • Resting heart rate: < 70/min
  • Supplementation with dietary supplements or drugs which contains amino acids, vitamins and other micronutrients
  • Therapy with antipsychotic drugs such as tranquilizer, antidepressants
  • acute and chronic diarrhea
  • Psychological-neurological or psychiatric therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: amino acid composition (asn01)
Dietary supplement: specific amino acid composition with micronutrients

Amino acid composition with micronutrients, once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water.

Duration: 12 weeks

Other Names:
  • Brand name: aminoplus neurostress
PLACEBO_COMPARATOR: Sugar powder
Placebo contains no amino acids and no micronutrients and is identical in appearance and solution properties.

Placebo; once a day (in the evening, 2 hours after dinner) content of a sachet mixed with 200 ml water.

Placebo contains no amino acids and micronutrients and is identical in appearance and solution properties.

Duration: 12 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological neurological questionnaire (PNF)
Time Frame: 12-week dietary intervention
Pre-post intervention changes in total number of points PNF
12-week dietary intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychological neurological questionnaire (PNF)
Time Frame: 12-week dietary intervention
Pre-post improvement in total number of points from the psychological-neurological questionnaire (PNF) about 10 Points or more
12-week dietary intervention
Salivary cortisol concentration (30 minutes after waking in the morning)
Time Frame: 12-week dietary intervention
Absolute difference between cortisol concentration at baseline and 12 weeks
12-week dietary intervention
Salivary cortisol concentration (in the evening between 8 and 10 pm, 2 hours after dinner)
Time Frame: 12-week dietary intervention
Absolute difference between cortisol concentration at baseline and 12 weeks
12-week dietary intervention
Serotonin concentration in blood
Time Frame: 12-week dietary intervention
Absolute difference between serotonin concentration at baseline and 12 weeks
12-week dietary intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (ACTUAL)

May 1, 2012

Study Completion (ACTUAL)

June 1, 2012

Study Registration Dates

First Submitted

August 26, 2011

First Submitted That Met QC Criteria

August 29, 2011

First Posted (ESTIMATE)

August 30, 2011

Study Record Updates

Last Update Posted (ESTIMATE)

September 7, 2015

Last Update Submitted That Met QC Criteria

September 4, 2015

Last Verified

September 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nervous System Disorder

Clinical Trials on amino acid composition (asn01)

Subscribe